ProMIS Neurosciences Inc. is a clinical stage biotechnology company focused on developing antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases. The company serves markets related to Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple system atrophy.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.